Sarma, A., Kataki, A., Rai, A., Hazarika, M., Roy, P., Kalita, M., Deka, M., & Chattopadhyay, I. (2023). Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association with Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India. Asian Pacific Journal of Cancer Care, 8(1), 35-42.